catalyst

Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With A — primary completion

as of 2026-07-01
at a glance
2020-01-08 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With A — primary completion
Type
Trial Readout
Date
2020-01-08
Date type
ACTUAL
Phase
Phase 3
This event happened.